R
RAD
RADIOPHARM
0.019
-0.001-5.00%Closed16:10 07/10 AEST
OPEN/PREV CLOSE0.019/0.020
TODAY RANGE0.019-0.020
VOL1.40M
MARKET CAP67.34M
52 WEEK RANGE0.017-0.040
AVG VOL (3M)4.09M
% TURNOVER0.04%
TURNOVER26.68K
P/E (TTM)-1.2418
% RANGE5.00%
EPS(TTM)-0.0153
P/E(FORWARD)-1.8812
P/B1.301
BVPS0.015
DIVIDEND--
P/S12.67
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP48.42M
SHARES OUTSTANDING3.54B
NEXT EARNINGS--
FREE FLOAT2.55B
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
ASX·07/03 05:20
Radiopharm Receives $5.9M R&D Tax Incentive-RAD.AX
ASX·06/30 06:15
Notification regarding unquoted securities - RAD-RAD.AX
ASX·06/30 06:05
Notification of cessation of securities - RAD-RAD.AX
ASX·06/03 02:08
Notification of cessation of securities - RAD-RAD.AX
ASX·04/30 23:54
Financial Services and Company Secretary Changes
ASX·04/23 00:00
RADIOPHARM THERANOSTICS LIMITED Prelim Q3
ASX·04/19 22:55
RAD Initial Findings from Phase 1 177Lu-RAD202 Trial
ASX·04/15 22:43
RAD Completes Enrollment in Phase 2b Trial of RAD 101
ASX·04/07 23:02
RAD202 Phase 1 HEAT Trial Advances to Dose Level 3
ASX·04/06 22:33
RAD and Siemens Sign Clinical Supply Agreement for RAD101
ASX·03/31 04:54
Change of Director's Interest Notice (IT)
ASX·03/26 21:24
RAD Doses First Patient in RAD 402 Phase 1 Clinical Study
ASX·03/23 22:35
RAD101 2nd interim Ph.2b data - 90% achieve primary endpoint
ASX·03/18 23:10
RAD to present at NWR Virtual Healthcare Conference
ASX·02/27 02:04
Half Year Report and Appendix 4D 31 December 2025
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others